LMB In The News


Unlocking the secrets of the brain

Madeline Lancaster, from the LMB’s Cell Biology Division, discusses how lab-grown ‘mini-brains’ could be the key to solving the biggest mysteries about human brain development and disease. More…

Published

The circadian rhythm of life

John O’Neill, from the LMB’s Cell Biology Division, discusses how unravelling the complex mechanisms of the body clock has led to some fascinating discoveries worthy of the 2017 Nobel Prize in Physiology or Medicine. More

Published

Magnetic attraction of AstraZeneca to MRC LMB

cambridge independent logo

AstraZeneca has moved it Nuclear Magnetic Resonance laboratory to the LMB while its new global R&D centre is built nearby. More

Published

Alcohol can cause irreversible genetic damage to stem cells, says study

Link between drinking and cancer clarified by study – led by KJ Patel’s group in the LMB’s PNAC Division – which indicates alcohol causes cancer by scrambling DNA in cells, eventually leading to mutations. More…

Published

Scientists establish a comprehensive protein interactions map of the replication machinery of a chronic virus

Chronic viral infections are amongst the biggest threats to human health worldwide. Leo James’ group from the LMB’s PNAC Division, in collaboration with scientists at the Austrian Academy of Sciences and University of Basel, have established the first comprehensive overview of cellular proteins interacting with the LCMV polymerase. It is hoped that the research leads to a better understanding of how chronic viral infections start and the complex molecular interactions between viruses and their hosts. More…

Published

Distinct human mutations can alter the effect of medicine

University of Copenhagen logo

About one third of all medicine binds to the same type of receptor in the human body. An estimated 3 percent of the population have receptors of this type that are so genetically different that they are predisposed to altered, ineffective or adverse responses to medicine, a new study from the University of Copenhagen and the MRC Laboratory of Molecular Biology in Cambridge shows. More…

Published

GPCR structures aided drug design

Chemical & Engineering News (C&EN)

A decade after a key structural analysis, scientists have a better understanding of the pharmaceutically important family of receptor proteins – G protein-coupled receptors (GPCR).  Includes reference to the work done at the LMB by Chris Tate. More...

Published

Potassium is critical to circadian rhythms in human red blood cells

An innovative new study from the University of Surrey and John O’Neill’s group from the LMB’s Cell Biology Division has uncovered the secrets of the circadian rhythms in red blood cells and identified potassium as the key to unravelling the mystery. More…

Published

LMB postdoc, Tobias Wauer, wins the 2017 EMPRIS Award for Research in Brain Diseases

LMB postdoctoral researcher, Tobias Wauer, has won the 2017 EMPRIS Award for Research in Brain Diseases for his work on the molecular causes of Parkinson’s disease. In this interview, he explains his fascination for research. More…

Published

LMB scientist, Glenn Masson, spends a week shadowing MP for Cambridge, Daniel Zeichner, through the Royal Society’s Pairing Scheme

Glenn Masson has spent a week shadowing Daniel Zeichner, MP for Cambridge, through the Royal Society’s Pairing Scheme, an initiative which pairs scientists with MPs to foster exchange of knowledge and understanding of politics, policy and science. More…

Published